Language
English
German
^M
Dutch
Spanish
Title:
Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease
Source:
Analytical Chemistry [0003-2700] Hamler, Rick yr:2017
Basic
Full text
Full text available via
American Chemical Society Journals
Year:
Volume:
Issue:
Start Page:
Document delivery
Request document via
Library/Bibliothek
Users interested in this article also expressed an interest in the following:
description
1.
Soria, Federico N.
"Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration."
Human molecular genetics
26.14 (2017): 2603-2615.
description
2.
Hopwood, J.
"Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease."
Neurobiology of disease
91 (2016): 143-154.
description
3.
Farfel Becker, T.
"Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration."
Human molecular genetics
23.4 (2013): 843-54.
description
4.
Hallett, Penelope J.
"Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain."
Neurobiology of aging.
67: 189-200.
description
5.
Sharma, Sandeep K.
"Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson’s disease."
Cellular and Molecular Life Sciences
74.4 (2017): 617-629.
description
6.
Malenka, Robert C.
"Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons."
Neuron
85.2 (2015): 429-38.
description
7.
Akiyama, H.
"Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1."
Biochemical and biophysical research communications
441.4 (2013): 838-43.
description
8.
Cullen, V.
"Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing."
Annals of neurology
69.6 (2011): 940-953.
description
9.
Tropak, M.
"Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease."
The Journal of biological chemistry
284.35 (2009): 23502-23516.
description
10.
Ghauharali-van der Vlugt K, Langeveld M, Poppema A, K.
"Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease."
Clinica chimica acta
389.1-2 (2008): 109-113.
description
11.
Orvisky, E.
"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype."
Molecular genetics and metabolism
76.4 (2002): 262-70.
description
12.
Kantak, Pranish A.
"Considerations when using cre-driver rodent lines for studying ventral tegmental area circuitry."
Neuron
85.2 (2015): 439-45.
description
13.
Langeveld, M.
"Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance."
The Journal of clinical endocrinology and metabolism
93.3 (2008): 845-851.
description
14.
Ginzburg, L.
"The pathogenesis of glycosphingolipid storage disorders."
Seminars in cell & developmental biology
15.4 (2004): 417-431.
description
15.
Cisneros, Irma E.
"Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes."
Neuropharmacology.
135: 431-443.
description
16.
Kubo, S.
"Membrane lipids as therapeutic targets for Parkinson’s disease: a possible link between Lewy pathology and membrane lipids."
Expert opinion on therapeutic targets
20.11 (2016): 1301-1310.
description
17.
Rokad, D.
"Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation."
Brain research bulletin
133 (2016): 60-70.
description
18.
Bose, S.
"Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders."
Ageing research reviews
35 (2016): 155-175.
description
19.
Murugesan, V.
"Glucosylsphingosine is a key biomarker of Gaucher disease."
American journal of hematology
91.11 (2016): 1082-1089.
description
20.
Yerbury, J.
"Walking the tightrope: proteostasis and neurodegenerative disease."
Journal of neurochemistry
137.4 (2016): 489-505.
View More...
View Less...
Select All
Clear All
Save Citations
Select Format
ProCite
Reference Manager
EndNote
RefWorks
Submit citation export
Advanced
Author
Other articles by this author? -- in
GeoRef
author:
Hamler, Rick
Brignol, Nastry
Clark, Sean W
Morrison, Sean
Dungan, Leo B
Chang, Hui H
Khanna, Richie
Frascella, Michelle
Valenzano, Kenneth J
Benjamin, Elfrida R
Boyd, Robert E
last name
initials
Other articles by this author? -- in
Online Contents Geosciences
author:
Hamler, Rick
Brignol, Nastry
Clark, Sean W
Morrison, Sean
Dungan, Leo B
Chang, Hui H
Khanna, Richie
Frascella, Michelle
Valenzano, Kenneth J
Benjamin, Elfrida R
Boyd, Robert E
last name
initials
Other articles by this author? -- using
Web of Science
author:
Hamler, Rick
Brignol, Nastry
Clark, Sean W
Morrison, Sean
Dungan, Leo B
Chang, Hui H
Khanna, Richie
Frascella, Michelle
Valenzano, Kenneth J
Benjamin, Elfrida R
Boyd, Robert E
last name
initials
Web Search
Find related information in
a Web Search Engine
Excite
Google
HotBot
Ixquick
ZOO
Ask
Yahoo!
Bing
Naver
Search Terms:
Search for related information in
Google Scholar
Article Title
Author Name
Journal Title
Other Search
Search Terms:
A service provided by the
Library of the Wissenschaftspark Albert Einstein
, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.